Publications by authors named "Pilar Font"

Claim this Profile
P
Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs.
Laura Muñoz-Barrera, Carlos Perez-Sanchez, Rafaela Ortega-Castro, Sagrario Corrales, Maria Luque-Tevar, Pilar Font

Biomed Pharmacother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of neovascular age-related macular degeneration within 48 h from diagnosis improves long-term functional outcome.
Raúl Martínez-Castillo, Carmen González-Gallardo, José I Muñoz-Ávila, Pilar Font, Marta Villalba-González

Biomed Pharmacother· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenic mechanisms involving the interplay between adipose tissue and auto-antibodies in rheumatoid arthritis.
Iván Arias-de la Rosa, Alejandro Escudero-Contreras, Miriam Ruiz-Ponce, Laura Cuesta-López, Cristóbal Román-Rodríguez, Pilar Font

iScience· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy.
Alejandro Ibáñez-Costa, Carlos Perez-Sanchez, Alejandra María Patiño-Trives, Maria Luque-Tevar, Pilar Font

Ann Rheum Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs.
Iván Arias de la Rosa, Alejandro Escudero-Contreras, Miriam Ruiz-Ponce, Cristóbal Román-Rodríguez, Carlos Pérez-Sánchez, Pilar Font

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real clinical impact of drug-drug interactions of immunosuppressants in transplant patients.
Ana Isabel Gago-Sánchez, Pilar Font, Manuel Cárdenas, María Dolores Aumente, José Ramón Del Prado

Pharmacol Res Perspect· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid Arthritis.
Maria Luque-Tévar, Carlos Perez-Sanchez, Alejandra Mª Patiño-Trives, Nuria Barbarroja, Ivan Arias de la Rosa, Pilar Font

Front Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation.
Alejandra María Patiño-Trives, Carlos Pérez-Sánchez, Laura Pérez-Sánchez, María Luque-Tévar, M Carmen Ábalos-Aguilera, Pilar Font

Arterioscler Thromb Vasc Biol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of elevation and external rotation in the shoulder: Reverse total shoulder arthroplasty combined with latissimus dorsi transfer to the humerus versus the greater tuberosity.
Manuel Zafra, Pilar Uceda, Francisco Muñoz, Carmen Ruiz-Bonilla, Pilar Font

Shoulder Elbow· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: Data from COMOSPA.
Marta Arévalo, Clementina López-Medina, Mireia Moreno Martinez-Losa, Anna Moltó, Pilar Font

Joint Bone Spine· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis.
Iván Arias de la Rosa, Pilar Font, Alejandro Escudero-Contreras, María Dolores López-Montilla, Carlos Pérez-Sánchez

Ther Adv Chronic Dis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Characterization of Monocyte Subsets Reveals Specific and Distinctive Molecular Signatures Associated With Cardiovascular Disease in Rheumatoid Arthritis.
Patricia Ruiz-Limon, Rafaela Ortega-Castro, Nuria Barbarroja, Carlos Perez-Sanchez, Christophe Jamin, Pilar Font

Front Immunol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arthroscopic repair of partial-thickness articular surface rotator cuff tears: single-row transtendon technique versus double-row suture bridge (transosseous equivalent) fixation: results from a prospective randomized study.
Manuel Zafra, Pilar Uceda, Francisco Muñoz-Luna, Rafael C Muñoz-López, Pilar Font

Arch Orthop Trauma Surg· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database.
Marta Arévalo, Jordi Gratacós Masmitjà, Mireia Moreno, Joan Calvet, Cristobal Orellana, Pilar Font

Arthritis Res Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should over-treatment of axial spondyloarthritis with biologics remain a concern after the issue of the new ASAS criteria? Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides).
Mireia Moreno, Jordi Gratacós, Victoria Navarro-Compán, Eugenio de Miguel, Pilar Font

Clin Exp Rheumatol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database.
Marta Arévalo, Jordi Gratacós Masmitjà, Mireia Moreno, Joan Calvet, Cristobal Orellana, Pilar Font

Arthritis Res Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of biological therapy in rheumatoid arthritis patients: outcomes from the CREATE registry after 2 years of follow-up.
Manuel J Cárdenas, Soraya de la Fuente, María C Castro-Villegas, Montserrat Romero-Gómez, Desiré Ruiz-Vílchez, Pilar Font

Rheumatol Int· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation.
Patricia Ruiz-Limón, Rafaela Ortega, Ivan Arias de la Rosa, Maria Del Carmen Abalos-Aguilera, Carlos Perez-Sanchez, Pilar Font

Transl Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy.
Nathan Vastesaeger, Bert Vander Cruyssen, Juan Mulero, Jordi Gratacós Masmitjá, Pedro Zarco, Pilar Font

Reumatol Clin· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etoricoxib in ankylosing spondylitis: is there a role for active patients refractory to traditional NSAIDs?
Jordi Gratacós, Mireia Moreno Martínez-Losa, Pilar Font, Carlos Montilla, Cruz Fernández-Espartero

Clin Exp Rheumatol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα.
Carmen Castro-Villegas, Carlos Pérez-Sánchez, Alejandro Escudero, Ileana Filipescu, Miriam Verdu, Pilar Font

Arthritis Res Ther· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ankylosing spondylitis without axial progression: analysis of associated factors.
Carlos Montilla, Agustín Díaz-Alvarez, Ismael Calero-Paniagua, Eduardo Collantes-Estevez, Pilar Font

J Rheumatol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candidate's single-nucleotide polymorphism predictors of treatment nonresponse to the first anti-TNF inhibitor in ankylosing spondylitis.
Ruxandra Schiotis, Alejandra Sánchez, Alejandro Escudero, Nerea Bartolomé, Magdalena Szczypiorska, Pilar Font

Rheumatol Int· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures.
Manuel Riesco, Francisco Manzano, Pilar Font, Alicia García, Joan M Nolla

Clin Rheumatol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America.
Mariana Benegas, Elisa Muñoz-Gomariz, Pilar Font, Ruben Burgos-Vargas, José Chaves

J Rheumatol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis